



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Monday,
                        11 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    HEALTH AND FAMILY WELFARE






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

709






                                    ANSWERED ON: 
                                

05.02.2021






COVID-19 Vaccination in Tamil Nadu




Andimuthu Raja














                        Will the Minister of





HEALTH AND FAMILY WELFARE


                        be pleased to state:-















                                                    Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:(a) the details of COVID-19 vaccine supplied, vaccination programme/session conducted in the State of Tamil Nadu, district-wise;(b) the number of beneficiaries vaccinated thereof;(c) whether large number of adverse effects are reported post COVID-19 vaccination in the country, especially in Tamil Nadu, if so, the details thereof;(d) the details of the number of persons suffered post COVID vaccination and hospitalized; and(e) the details of the steps taken by the Government to bear the hospitalization cost of such people?






ANSWER




                                                        ANSWERTHE MINISTER OF STATE IN THE MINISTRY OF HEALTH AND FAMILY WELFARE(SHRI ASHWINI KUMAR CHOUBEY)(a):	A total of 12.34 lakh doses of COVID-19 vaccines have been supplied to the State of Tamil Nadu. The district-wise detail of vaccine distribution is at Annexure 1.Till 2nd February 2021, a total of 3,634 vaccination sessions have been conducted in the State of Tamil Nadu. The district-wise details is at Annexure-2(b):	A total of 1,20,745 beneficiaries have been vaccinated in the State of Tamil Nadu till 02nd February 2021. The district-wise details is at Annexure-2(c):	A total of 7,580 Adverse Events Following Immunization (AEFI) have been reported following COVID-19 vaccination, of which 42 AEFIs have been reported from Tamil Nadu. Majority of these AEFIs are minor in nature like pain at injection site, fever, malaise etc.(d):	A total of 22 hospitalizations have been reported following COVID-19 vaccination till 2nd February 2021.(e):	All States and UTs have been advised to provide free medical care at public health care facilities to all cases of AEFIs.
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113200433







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







